Levalbuterol recalls
The FDA has published 3 recalls involving Levalbuterol since 2015. The latest was reported on 15 Jun 2022. Most were for manufacturing (cgmp) deviations. Mckesson Medical-Surgical Inc. Corporate Office has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why levalbuterol is recalled
Companies
By year
All levalbuterol recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Levalbuterol Tartrate HFA Inhalation Aerosol recalledLevalbuterol Tartrate Hfa Inhalation | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Levalbuterol tartrate HFA Inhalation Aerosol recalled by Cardinal HealthLevalbuterol Tartrate Hfa Inhalation | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS III | Levalbuterol Inhalation Solution, USP, 0.31 mg/ Vials recalled by Cipla | Cipla | Potency & Assay | Nationwide |
Should you stop taking Levalbuterol?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.